Federal award (BPA CALL, fiscal year 2022)
Recipient: PROGENICS PHARMACEUTICALS INC
Awarding agency: Department of Defense / Department of the Navy
Funding agency: Department of Defense / Defense Health Agency
Period of performance: 2022-10-05 to 2022-10-17
Current total value of award: $49189.98
Description: PILARIFY (PIFLUFOLASTAT F-18) INJECTION: QTY 14